Veiveriečių sveikata - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 151,890 | 180,690 | 207,443 | 297,375 | 291,557 | 307,658 | 324,872 |
| Profit before tax | - | - | - | - | 38,006 | -17,337 | 39,297 | 7,585 |
| Net profit | - | - | - | - | 38,006 | -17,337 | 39,297 | 7,585 |
| Equity | 26,679 | 43,100 | 60,249 | 57,851 | 95,857 | 78,519 | 117,816 | 125,401 |
| Liabilities | 2,629 | 2,901 | 4,597 | 7,403 | 6,425 | 18,176 | 19,893 | 23,449 |
| Non-current assets | 4,486 | 18,283 | 18,197 | 16,966 | 18,813 | 8,350 | 2,897 | - |
| Current assets | 24,822 | 39,120 | 55,475 | 54,538 | 87,143 | 89,443 | 134,812 | - |
| Total assets | 29,308 | 57,403 | 73,672 | 71,504 | 105,956 | 97,793 | 137,709 | 0 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 37,885 | 33,439 | 38,362 |
| Social insurance contributions | - | - | - | - | - | 51,527 | 44,444 | 51,046 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +19.0% | +14.8% | +43.4% | -2.0% | +5.5% | +5.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 35.9% | -17.7% | 28.5% | - |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 39.6% | -22.1% | 33.4% | 6.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 12.8% | -5.9% | 12.8% | 2.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 12.8% | -5.9% | 12.8% | 2.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 16,877 | 18,375 | 20,404 | 24,954 | 23,481 | 23,666 | 24,831 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Veiveriečių sveikata - Social security debts
The company had no debts to Sodra
Veiveriečių sveikata - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Veiverieciu sveikata, VšI (code 170792752) is a Public Institution engaged in general medical practice activities. In the latest financial year, 2025, revenue increased to €324.9K, up 5.6% year on year and 11.4% over two years. Net profit was €7.6K, down from €39.3K in 2024, and the profit margin narrowed to 2.3% after 12.8% a year earlier. The 2023 base was weaker, with revenue of €291.6K and a net loss of €17.3K, so the three-year trajectory shows moderate turnover growth alongside fluctuating profitability. Equity strengthened from €78.5K in 2023 to €117.8K in 2024 and €125.4K in 2025, while liabilities rose to €23.4K. Total assets were €137.7K in 2024. The latest ratios indicate a return on equity of 6.0%, debt-to-equity of 0.19 and revenue per employee of €25.0K, with profit per employee of €583. Overall, the company remained profitable in 2025, but at a much lower level than in 2024.